PL1615638T3 - Zastosowanie pochodnych 7-nitro-2,1,3-benzoksadiazolu do terapii przeciwrakowej - Google Patents

Zastosowanie pochodnych 7-nitro-2,1,3-benzoksadiazolu do terapii przeciwrakowej

Info

Publication number
PL1615638T3
PL1615638T3 PL04728231T PL04728231T PL1615638T3 PL 1615638 T3 PL1615638 T3 PL 1615638T3 PL 04728231 T PL04728231 T PL 04728231T PL 04728231 T PL04728231 T PL 04728231T PL 1615638 T3 PL1615638 T3 PL 1615638T3
Authority
PL
Poland
Prior art keywords
nitro
anticancer therapy
benzoxadiazole
derivatives
benzoxadiazole derivatives
Prior art date
Application number
PL04728231T
Other languages
English (en)
Inventor
Anna Maria Caccuri
Giorgio Ricci
Original Assignee
Univ Degli Studi Di Roma Tor Vergata
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Di Roma Tor Vergata filed Critical Univ Degli Studi Di Roma Tor Vergata
Publication of PL1615638T3 publication Critical patent/PL1615638T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL04728231T 2003-04-24 2004-04-19 Zastosowanie pochodnych 7-nitro-2,1,3-benzoksadiazolu do terapii przeciwrakowej PL1615638T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000194A ITRM20030194A1 (it) 2003-04-24 2003-04-24 Uso di derivati del 7-nitro-2, 1, 3-benzossadiazolo per
PCT/IT2004/000223 WO2004093874A1 (en) 2003-04-24 2004-04-19 Use of 7-nitro-2,1,3 benzoxadiazole derivatives for anticancer therapy
EP04728231A EP1615638B1 (en) 2003-04-24 2004-04-19 Use of 7-nitro-2,1,3 benzoxadiazole derivatives for anticancer therapy

Publications (1)

Publication Number Publication Date
PL1615638T3 true PL1615638T3 (pl) 2007-01-31

Family

ID=29765779

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04728231T PL1615638T3 (pl) 2003-04-24 2004-04-19 Zastosowanie pochodnych 7-nitro-2,1,3-benzoksadiazolu do terapii przeciwrakowej

Country Status (11)

Country Link
US (1) US8796317B2 (pl)
EP (1) EP1615638B1 (pl)
AT (1) ATE340573T1 (pl)
DE (1) DE602004002584T2 (pl)
DK (1) DK1615638T3 (pl)
ES (1) ES2274449T3 (pl)
IT (1) ITRM20030194A1 (pl)
PL (1) PL1615638T3 (pl)
PT (1) PT1615638E (pl)
SI (1) SI1615638T1 (pl)
WO (1) WO2004093874A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2304112B1 (es) * 2007-02-23 2009-08-13 Universidad De Zaragoza Uso de compuestos como inhibidores de la flavodoxina de helicobacter.
ES2304220B1 (es) * 2007-03-02 2009-09-11 Universidad De Zaragoza Composicion para el tratamiento de enfermedades infecciosas.
ES2304221B1 (es) * 2007-03-02 2009-09-11 Universidad De Zaragoza Composicion para el tratamiento de enfermedades infecciosas causadas por helicobacter.
WO2008124838A1 (en) * 2007-04-10 2008-10-16 University Of Maryland, Baltimore Compounds that inhibit human dna ligases and methods of treating cancer
FR2919287B1 (fr) * 2007-07-26 2012-10-12 Pf Medicament Nouveaux derives fluorescents de polyamines, leur procede de preparation et leurs applications en tant qu'outils de diagnostic dans le traitement des tumeurs cancereuses.
GB0717982D0 (en) * 2007-09-14 2007-10-24 Univ Durham Method and means relating to multiple herbicide resistance in plants
ITRM20120178A1 (it) * 2012-04-24 2013-10-25 Uni Degli Studi G D Annun Zio Di Chieti Derivati del 7-nitro-2,1,3-benzossadiazolo per terapia antitumorale
US11117877B2 (en) 2014-11-21 2021-09-14 Bsim Therapeutics, S.A. 2-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof
EP3307723B1 (en) 2015-06-15 2020-11-11 BSIM2 - Biomolecular Simulations, S.A. Bis-furan derivatives as transthyretin (ttr) stabilizers and amyloid inhibitors for the treatment of familial amyloid polyneuropathy (fap)
CN109553590B (zh) * 2018-11-22 2022-04-26 东南大学 具有谷胱甘肽巯基转移酶抑制功能的化合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10045599B4 (de) * 2000-09-15 2004-06-03 Wella Ag Haarfärbemittel auf der Basis von 4-Nitro-2,1,3-benzoxadiazol-Derivaten und dessen Verwendung als Farbstoff zum Färben von Haaren

Also Published As

Publication number Publication date
EP1615638B1 (en) 2006-09-27
DE602004002584D1 (de) 2006-11-09
EP1615638A1 (en) 2006-01-18
WO2004093874A1 (en) 2004-11-04
ATE340573T1 (de) 2006-10-15
ITRM20030194A0 (it) 2003-04-24
SI1615638T1 (sl) 2007-02-28
DE602004002584T2 (de) 2007-10-25
US8796317B2 (en) 2014-08-05
PT1615638E (pt) 2007-01-31
DK1615638T3 (da) 2007-01-08
ES2274449T3 (es) 2007-05-16
ITRM20030194A1 (it) 2004-10-25
US20060247284A1 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
Bai et al. Cell cycle regulation and anticancer drug discovery
EA200401318A1 (ru) Производные хинолинона
PL1615638T3 (pl) Zastosowanie pochodnych 7-nitro-2,1,3-benzoksadiazolu do terapii przeciwrakowej
SG127738A1 (en) Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, pharmaceutical preparations containing these compounds
MY148072A (en) Oxygen linked pyrimidine derivatives
HUP0303271A2 (hu) Rapamycin felhasználása rák kezelésére alkalmas gyógyszerkészítmény elõállítására
GB0402809D0 (en) Chemical compounds
TW200730502A (en) Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
BR0100014A (pt) Compostos de benzimidazol como agonistas do receptor orl1
WO2005037205A3 (en) Haloacetamide and azide substituted compounds and methods of use thereof
MX2009009574A (es) Tratamiento de melanoma.
MY138923A (en) Combination chemotherapy
GEP20053626B (en) Substituted 8-Arylquinoline Phosphodiesterase-4 Inhibitors, Pharmaceutical Composition Containing Them and Use Thereof
CA2663965A1 (en) Pyrazolopyrimidine derivative and use thereof as an anticancer agent
UY30175A1 (es) Combinacion farmacéutica para el tratamiento y/o quimiosensibilizacion de tumores refractarios a drogas anticancerigenas
GEP20104875B (en) Pyrimidine derivatives for the treatment of abnormal cell growth
UA83832C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и их применение
SI1095040T1 (en) New benzoxazoles with pde-inhibiting activity
SG155939A1 (en) Phosphoindoles as hiv inhibitors
BR0317950A (pt) Inibidores de quinurrenina 3-hidroxilase para o tratamento de diabetes por aumento do número de ilhotas de células de langerhans
WO2008006974A3 (fr) Utilisation de ligands du recepteur h4 de l'histamine pour proteger les progeniteurs hematopoïetiques contre la toxicite hematologique des agents chimiotherapeutiques.
MX2009005125A (es) Pirrolo[1,2-a]imidazoldiona efectiva en el tratamiento de neurotoxicidad periferica inducida por agentes quimioterapeuticos.
Saotome et al. Combination chemotherapy with irinotecan and adriamycin for refractory and relapsed non-Hodgkin's lymphoma
RS20050776A (en) A synergistic pharmaceutical combination comprising cicletanine for the prevention or treatment diabetes
Asif A mini review on pharmacological activities of oxadiazole and thiadiazole compounds